Large-scale testing (Phase 3)Study completedNCT03946111
What this trial is testing
Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Medication Change for Non-Responders
Who this might be right for
Binge-Eating DisorderObesity
Yale University 3